Heart implant maker BioVentrix withdraws plans for Nasdaq IPO
BioVentrix has withdrawn its plans to go public, after pitching a Nasdaq IPO earlier this year that aimed to raise about $17 million. In a filing with the SEC, the Massachusetts-based company said the terms of the offering were never set and no securities …